A detailed history of Chatham Capital Group, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 6,378 shares of XBI stock, worth $581,928. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,378
Previous 6,228 2.41%
Holding current value
$581,928
Previous $577,000 9.19%
% of portfolio
0.1%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$90.87 - $102.43 $13,630 - $15,364
150 Added 2.41%
6,378 $630,000
Q2 2024

Jul 15, 2024

SELL
$82.22 - $94.12 $6,577 - $7,529
-80 Reduced 1.27%
6,228 $577,000
Q4 2023

Jan 19, 2024

SELL
$64.12 - $90.86 $5,770 - $8,177
-90 Reduced 1.41%
6,308 $563,000
Q1 2023

Apr 21, 2023

SELL
$73.13 - $91.97 $9,141 - $11,496
-125 Reduced 1.92%
6,398 $487,000
Q4 2022

Jan 31, 2023

SELL
$76.72 - $85.66 $3,836 - $4,283
-50 Reduced 0.76%
6,523 $541,000
Q3 2022

Oct 28, 2022

BUY
$75.06 - $94.9 $150 - $189
2 Added 0.03%
6,573 $521,000
Q2 2022

Aug 02, 2022

SELL
$62.81 - $96.09 $11,305 - $17,296
-180 Reduced 2.67%
6,571 $488,000
Q1 2022

Apr 21, 2022

SELL
$81.07 - $115.44 $231,860 - $330,158
-2,860 Reduced 29.76%
6,751 $607,000
Q4 2021

Feb 02, 2022

SELL
$108.77 - $134.15 $27,192 - $33,537
-250 Reduced 2.54%
9,611 $1.08 Million
Q3 2021

Oct 13, 2021

SELL
$118.69 - $138.49 $11,869 - $13,849
-100 Reduced 1.0%
9,861 $1.24 Million
Q2 2021

Jul 28, 2021

BUY
$122.48 - $139.69 $244 - $279
2 Added 0.02%
9,961 $1.35 Million
Q1 2021

Apr 29, 2021

BUY
$129.36 - $173.99 $4,268 - $5,741
33 Added 0.33%
9,959 $1.35 Million
Q4 2020

Jan 27, 2021

BUY
$110.36 - $151.14 $13,022 - $17,834
118 Added 1.2%
9,926 $1.4 Million
Q3 2020

Oct 22, 2020

BUY
$103.87 - $120.36 $6,024 - $6,980
58 Added 0.59%
9,808 $1.09 Million
Q2 2020

Jul 20, 2020

BUY
$73.26 - $114.17 $28,864 - $44,982
394 Added 4.21%
9,750 $1.09 Million
Q1 2020

May 01, 2020

SELL
$65.95 - $98.35 $2.95 Million - $4.4 Million
-44,759 Reduced 82.71%
9,356 $725,000
Q4 2019

Jan 31, 2020

SELL
$74.65 - $98.46 $423,265 - $558,268
-5,670 Reduced 9.48%
54,115 $5.15 Million
Q3 2019

Nov 08, 2019

SELL
$76.25 - $83.86 $154,406 - $169,816
-2,025 Reduced 3.28%
59,785 $4.56 Million
Q2 2019

Jul 24, 2019

BUY
N/A
705 Added 1.15%
61,810 $5.42 Million
Q1 2019

May 09, 2019

SELL
N/A
-2,340 Reduced 3.69%
61,105 $5.53 Million
Q4 2018

Feb 06, 2019

SELL
N/A
-10,040 Reduced 13.66%
63,445 $4.55 Million
Q3 2018

Oct 30, 2018

BUY
N/A
1,450 Added 2.01%
73,485 $7.05 Million
Q1 2018

May 09, 2018

BUY
N/A
1,265 Added 1.79%
72,035 $6.32 Million
Q4 2017

Feb 01, 2018

SELL
N/A
-1,600 Reduced 2.21%
70,770 $6.01 Million
Q3 2017

Nov 08, 2017

BUY
N/A
9,680 Added 15.44%
72,370 $6.27 Million
Q2 2017

Aug 09, 2017

BUY
N/A
62,690
62,690 $4.84 Million

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Chatham Capital Group, Inc. Portfolio

Follow Chatham Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.